Literature DB >> 4005182

Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis.

P Clezardin, J L McGregor, M Dechavanne, K J Clemetson.   

Abstract

Carbohydrate-specific surface labelling and 125I-labelled lectin binding techniques, in combination with one- or two-dimensional (non-reduced/reduced) SDS-polyacrylamide gel electrophoresis have been used with platelets from patients with myeloproliferation disorders and secondary thrombocytosis and from healthy donors. In essential thrombocythaemia platelet membrane glycoproteins were significantly less sialylated than in normals (particularly GP Ib and IIIa). Increased binding of 125I-labelled Lens culinaris lectin to thrombospondin and GP IIIa indicated a defect in the glucose/mannose glycosylation of the platelet glycoproteins in essential thrombocythaemia. In polycythaemia vera and in chronic myeloid leukaemia the terminal sialic acid of glycoprotein IIIb was labelled slightly more than normal. In chronic myeloid leukaemia there was increased labelling of the penultimate galactose/N-acetylgalactosamine residues of GP Ib, IIb, IIIa and IIIb. In comparison to myeloproliferative disorders, platelets from patients with secondary thrombocytosis showed no significant changes, except for platelets from two patients with idiopathic thrombocytopenic purpura which showed an increased sialylation of all surface glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005182     DOI: 10.1111/j.1365-2141.1985.tb07419.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.

Authors:  Huining Su; Mimi Wang; Xingchen Pang; Feng Guan; Xiang Li; Ying Cheng
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

Review 2.  The human platelet fibrinogen receptor: clinical and therapeutic significance.

Authors:  M Cahill; R Mistry; D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

3.  The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.

Authors:  María Virginia Tribulatti; Juan Mucci; Nico Van Rooijen; María Susana Leguizamón; Oscar Campetella
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm.

Authors:  Lamia Lamrani; Catherine Lacout; Véronique Ollivier; Cécile V Denis; Elizabeth Gardiner; Benoit Ho Tin Noe; William Vainchenker; Jean-Luc Villeval; Martine Jandrot-Perrus
Journal:  Blood       Date:  2014-06-20       Impact factor: 22.113

5.  Haemostatic Profile in Patients of Myeloproliferative Neoplasms-A Tertiary Care Centre Experience.

Authors:  Yatendra Parashar; Rashmi Kushwaha; Ashutosh Kumar; Kamal Agarwal; U S Singh; Mili Jain; S P Verma; A K Tripathi
Journal:  J Clin Diagn Res       Date:  2016-11-01

6.  [Megakaryocytic myelosis--clinical aspects, morphology and platelet function].

Authors:  A Hochhaus; D Höche; K Mindner; G Ostermann; M Meyer
Journal:  Klin Wochenschr       Date:  1989-01-20

7.  Redistribution of platelet membrane glycoprotein IV and release of intracellular alpha-granule thrombospondin in patients with chronic myelogenous leukemia.

Authors:  D Liu; D Shen; P Zou; W Wei; A Wang; R Yang
Journal:  J Tongji Med Univ       Date:  1997

8.  Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.

Authors:  J N George; E B Pickett; S Saucerman; R P McEver; T J Kunicki; N Kieffer; P J Newman
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.